KRAS G12D inhibitor 19
KRAS G12D inhibitor 19 (Compound 7) is a KRAS G12D inhibitor. KRAS G12D inhibitor 19 can be used for the research of cancer[1].
Product Specifications
CAS Number
2833695-47-7
UNSPSC
12352005
Target
Ras
Type
Reference compound
Related Pathways
GPCR/G Protein; MAPK/ERK Pathway
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/kras-g12d-inhibitor-19.html
Solubility
10 mM in DMSO
Smiles
FC1=C(C#C)C2=C(C3=NC=C4C(N=C(OCC5(CC5)CN6[C@@H](C7)CO[C@@H]7C6)N=C4N8C[C@H]9N[C@H](CC9)C8)=C3F)C=C(O)C=C2C=C1
Molecular Formula
C35H34F2N6O3
Molecular Weight
624.68
References & Citations
[1]Huifeng HAN, et al. Kras g12d inhibitors. Patent WO2022184178A1.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC470026-100 1x 100 µL
ACTH (Adrenocorticotrophic Hormone) (AH26), CF647 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC880630-100 1x 100 µL
Mucin 1 / EMA / Episialin / CD227 (VU-2G7), CF488A conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC880149-100 1x 100 µL
CD106 / VCAM1 (1.4C3), CF488A conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC041231-100 1x 100 µL
Eosinophil Peroxidase (AHE-1), CF405S conjugate, 0.1mg/mL
Sign In for Pricing
View Details 